GLP-1RAs (GLP-1 receptor agonists) are a class of drugs that mimic the action of the GLP-1 hormone and work by stimulating the production of insulin, slowing down food digestion and inducing satiety signals in the body
These reports may reflect individual variation, concurrent factors such as rapid weight loss (which can affect skin integrity), nutritional changes, or coincidental dermatological conditions rather than a direct drug effect
A 2025 Springer review on the topic confirmed that women with PCOS face unique metabolic challenges, including heightened insulin resistance, compounded by obesity that require targeted, not generic, interventions
21 Pharmacists should also counsel patients on the importance of maintaining adequate hydration, especially in the presence of vomiting or diarrhea, to prevent dehydration and reduce the risk of acute kidney injury
Anyone taking medications or managing a metabolic condition should get a medical evaluation before relying on a patch instead of supervised care
Brain Benefits: Neuroprotection and Mental Health Alzheimers and Neurodegeneration Researchers are investigating GLP-1 drugs as potential treatments for Alzheimers disease and Parkinsons disease
